Aggrega Pharma LLC is a U.S.-based pharmaceutical company created in 2019 by four European-based pharmaceutical companies (Bluepharma, Rafarm, Substipharm, Welding) focused on developing, manufacturing, and marketing generic drug products. The company leverages its shareholders' development and commercial manufacturing facilities, including FDA-inspected sites in Portugal and Greece, with capabilities in oral solids, sterile injectables, and complex ophthalmics.
Generic drug products, oral solid dosage, sterile injectables, complex ophthalmics, high-potency oral solids, nasal sprays, 505(b)(2) opportunities
4 sites worldwide
No reviews available yet.
No documents available.